Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7738428 | 0.78 | NR1H2 (0.54) | NR1H2NR1H3 | |
| SCHEMBL4267425 | 0.78 | NR1H2 (0.35) | NR1H2NR1H3 | |
| SCHEMBL16477651 | 0.77 | PYCR1 (0.37) | NR1H2NR1H3 | |
| SCHEMBL1219525 | 0.77 | ESR1 (0.41) | NR1H2NR1H3 | |
| SCHEMBL7874921 | 0.77 | ALDH1A1 (0.50) | NR1H2NR1H3 | |
| SCHEMBL7113522 | 0.77 | NR1H2 (0.33) | NR1H2NR1H3 | |
| SCHEMBL536223 | 0.76 | ALDH1A1 (0.36) | NR1H2NR1H3 | |
| SCHEMBL16477653 | 0.75 | APP (0.32) | NR1H2NR1H3 | |
| SCHEMBL7118374 | 0.74 | ALDH1A1 (0.35) | NR1H2NR1H3 | |
| SCHEMBL5026171 | 0.73 | NR1H2 (0.30) | NR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9228107-B2 | (Meth)allylsilane compound, silane coupling agent thereof, and functional material using the same | KYOEISHA CHEMICAL CO., LTD. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-9228107-B2 | (Meth)allylsilane compound, silane coupling agent thereof, and functional material using the same | KYOEISHA CHEMICAL CO., LTD. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-9228107-B2 | (Meth)allylsilane compound, silane coupling agent thereof, and functional material using the same | KYOEISHA CHEMICAL CO., LTD. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-20140200311-A1 | (METH)ALLYLSILANE COMPOUND, SILANE COUPLING AGENT THEREOF, AND FUNCTIONAL MATERIAL USING THE SAME | KYOEISHA CHEMICAL CO., LTD. (JP) | 2014-07-17 | — | — | US | disclosed |
| US-20140200311-A1 | (METH)ALLYLSILANE COMPOUND, SILANE COUPLING AGENT THEREOF, AND FUNCTIONAL MATERIAL USING THE SAME | KYOEISHA CHEMICAL CO., LTD. (JP) | 2014-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140200311-A1 | (METH)ALLYLSILANE COMPOUND, SILANE COUPLING AGENT THEREOF, AND FUNCTIONAL MATERIAL USING THE SAME | FGB, PFAS, MGMT | NR1H2 3441/4885NR1H3 3064/4885CNR1 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.